Clinical Trials Logo
  1. Home
  2. Uterine Hemorrhage
  3. NCT01726478

Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital

Uterine Hemorrhage Clinical Trial

Official title:
Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital; Adouble Blinded Clinical Trial.

Clinical Trial Summary

The purpose of the study was to determine whether 2.5 international units of oxytocin gives adequate uterine tone and is safe as compared to 10 international units of oxytocin following caesarean section delivery at Mulago hospital.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01726478
Study type Interventional
Source Makerere University
Contact
Status Completed
Phase N/A
Start date February 2011
Completion date April 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT00363389 - Hysteroscopy and Misoprostol Project Phase 3
Completed NCT01968135 - Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study Phase 2
Completed NCT04394234 - A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants
Completed NCT02147197 - A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas Phase 3
Completed NCT01295294 - Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA) Phase 4
Recruiting NCT04867109 - HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding
Completed NCT02147158 - A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas Phase 3
Completed NCT01254799 - Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA) Phase 3
Completed NCT00350480 - Treatment of Non-Gestational Acute Uterine Bleeding: A Randomized Trial N/A
Not yet recruiting NCT02453568 - Use of Tranexamic Acid for Prevention of Postpartum Hemorrhage and Routine Blood Loss in Obstetrics Phase 3